Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
Titel:
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
Auteur:
Dansky, Hayes M. Bloomfield, Daniel Gibbons, Patrice Liu, Sherry Sisk, Christine McCrary Tribble, Diane McKenney, James M. Littlejohn III, Thomas W. Mitchel, Yale